Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site mass, Vaccination site urticaria, Vaccination site vesicles
Clinical narrative: had blistering skin disease on injection site left arm and on the Feet & ankles; had blistering skin disease on injection site; She was diagnosed with a severe allergic reaction; had a red lump on the left arm injection site; on 18NOV2022, she had red itchy welts on left arm injection site; she had a Red Patch in the right eye and it was a little itching; On 30OCT2022, she had a Red Patch in the right eye and it was a little itching; This spontaneous case was reported by a consumer and describes the occurrence of EYE PRURITUS (she had a Red Patch in the right eye and it was a little itching), OCULAR HYPERAEMIA (On 30OCT2022, she had a Red Patch in the right eye and it was a little itching), BLISTER (had blistering skin disease on injection site left arm and on the Feet & ankles), VACCINATION SITE VESICLES (had blistering skin disease on injection site) and VACCINATION SITE URTICARIA (on 18NOV2022, she had red itchy welts on left arm injection site) in a 69-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 060F22A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: FLU. Past adverse reactions to the above products included No adverse event with FLU. Concurrent medical conditions included Blood pressure high. Concomitant products included CLOBETASOL, PREDNISONE, RAMIPRIL, METOPROLOL, CLOPIDOGREL BISULFATE (PLAVIX) from 14-Jun-2022 to an unknown date, ACETYLSALICYLIC ACID (ASPIRIN 81), PNEUMOCOCCAL VACCINE and INFLUENZA VACCINE (FLU [INFLUENZA VACCINE]) for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 30-Oct-2022, the patient experienced EYE PRURITUS (she had a Red Patch in the right eye and it was a little itching) and OCULAR HYPERAEMIA (On 30OCT2022, she had a Red Patch in the right eye and it was a little itching). On 18-Nov-2022, the patient experienced VACCINATION SITE URTICARIA (on 18NOV2022, she had red itchy welts on left arm injection site). On an unknown date, the patient experienced BLISTER (had blistering skin disease on injection site left arm and on the Feet & ankles), VACCINATION SITE VESICLES (had blistering skin disease on injection site), ALLERGY TO VACCINE (She was diagnosed with a severe allergic reaction) and VACCINATION SITE MASS (had a red lump on the left arm injection site). At the time of the report, EYE PRURITUS (she had a Red Patch in the right eye and it was a little itching), BLISTER (had blistering skin disease on injection site left arm and on the Feet & ankles), VACCINATION SITE VESICLES (had blistering skin disease on injection site), VACCINATION SITE URTICARIA (on 18NOV2022, she had red itchy welts on left arm injection site) and ALLERGY TO VACCINE (She was diagnosed with a severe allergic reaction) had not resolved and OCULAR HYPERAEMIA (On 30OCT2022, she had a Red Patch in the right eye and it was a little itching) and VACCINATION SITE MASS (had a red lump on the left arm injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Biopsy skin: Biopsy came back normal..     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided.   This case was linked to MOD-2022-691459 (Patient Link).